Hao-yang Xin
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Erratum: A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression.
Journal: Hepatology (Baltimore, Md.)
Published: August 14, 2025
The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 29, 2024
Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma.
Journal: Clinical and molecular hepatology
Published: April 25, 2024
Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
Journal: JAMA network open
Published: March 03, 2023
Corrigendum to 'Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence' [J Hepatol 71 (2019) 1152-63].
Journal: Journal of hepatology
Published: February 13, 2022
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
Journal: Journal of gastroenterology
Published: January 06, 2022
Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.
Journal: JAMA surgery
Published: November 03, 2021
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence.
Journal: Signal transduction and targeted therapy
Published: May 02, 2021
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2.
Journal: Clinical and translational medicine
Published: January 30, 2021
Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: October 01, 2020
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection.
Journal: Cancer cell international
Published: August 19, 2020
Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: February 16, 2020
Last Updated: 09/26/2026